PF-04360365 3 mg/kg

BIOLOGICAL2 trials

Sponsors

Pfizer

Conditions

Alzheimer's Disease

Phase 1

Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease

CompletedNCT00733642

PfizerAlzheimer's Disease

Start: 2008-08-31End: 2009-07-31Updated: 2009-07-28

Phase 2

Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

CompletedNCT00722046

PfizerAlzheimer's Disease

Start: 2008-12-05End: 2011-08-16Updated: 2022-11-07